|
KMID : 0370220220660050249
|
|
Yakhak Hoeji
2022 Volume.66 No. 5 p.249 ~ p.254
|
|
|
Developing National Level High-alert Medication Lists for Community/primary Care Patients
|
|
Lee Su-Hyun
Ah Young-Mi
Heo Kyu-Nam
Lee Ah-Young
Min Sang-Il
Kim A-Jeong
Kim Sung-Hwan
Jo Yun-Hee
Cho Yoon-Sook
Han Ji-Min
Lee Ju-Yeun
|
|
|
Abstract
|
|
|
|
Despite the fact that a considerable number of preventable adverse events are managed in primary care settings,medication-related risks have been evaluated mainly through hospital admissions. While interest in high-alert medicationmanagement in the community and primary care settings is increasing internationally, Korea does not have accreditationfor the same and lacks established standards for high-alert medications. Therefore, this study aimed to develop a nationallevellist of high-alert medications for community and primary care. The candidates for the high-alert medication listincluded medications recommended by Institute for Safe Medication Practices and those suggested by each guideline ofthe World Health Organization, Japan and Korea. We analyzed the adverse events related to medication errors reported bythe patients' safety reporting system. Seven experts working in the community and primary care settings evaluated theadequacy and priority of the candidate medications. The final list included 20 high-alert medications, including nineessential and eleven optional medications. The national-level list of high-alert medications which we developed may beuseful in formulating accreditation guidelines or treatment standards for community and primary care patients.
|
|
|
KEYWORD
|
|
|
High-alert medication, Community care patients, Primary care patients, Medication safety
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|